AI Article Synopsis

  • The study aimed to investigate how moxibustion can alleviate inflammation in rheumatoid arthritis (RA) by influencing ferroptosis and lipid metabolism.
  • Researchers used 48 rats divided into four groups (normal, model, moxibustion, and moxibustion with an ACSL4 inhibitor) to assess moxibustion's effects over 15 days using various biochemical and histological techniques.
  • Results showed that moxibustion significantly improved antioxidant levels and reduced inflammatory markers in the rats, indicating its potential as a treatment for RA-related synovitis.

Article Abstract

Objectives: To explore the mechanism of moxibustion in improving synovitis inflammatory injury in rheumatoid arthritis (RA) model rats based on the ferroptosis-lipid metabolism pathway.

Methods: Forty-eight SD rats were randomly divided into normal, model, moxibustion and moxibustion + long-chain acyl-CoA synthetase 4 (ACSL4) inhibitor groups, with 12 rats in each group. The RA model was replicated using environmental factors of wind, cold, and dampness combined with Freund's complete adjuvant injection. The moxibustion group received moxibustion at "Shenshu" (BL23) and "Zusanli" (ST36) for 20 minutes per acupoint each time, once daily at a single acupoint (both sides) with alternating acupoints over 15 consecutive days. The moxibustion + ACSL4 inhibitor group received intraperitoneal injection of the ACSL4 inhibitor rosiglitazone (0.4 mg/kg) after moxibustion, once daily for 15 consecutive days. Histopathological changes in synovial tissue were observed using HE staining;serum contents of glutathione (GSH) and malondialdehyde (MDA) were detected using biochemical methods;reactive oxygen species (ROS) levels in synovial tissues were detected using flow cytometry;the expressions of glutathione peroxidase 4 (GPX4), ACSL4, and lysophosphatidylcholine acyltransferase 3 (LPCAT3) proteins in synovial tissues were detected using Western blot;and serum contents of interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-α) were detected using ELISA.

Results: Compared with the normal group, the serum contents of GSH decreased (<0.01) while MDA, IL-6, and TNF-α contents increased (<0.01);the ROS levels, ACSL4 and LPCAT3 protein expressions increased (<0.01) while GPX4 protein expression decreased (<0.01) in synovial tissue in the model group. Compared with the model group, the serum contents of GSH increased (<0.01) while MDA, IL-6, and TNF-α contents decreased (<0.01);the ROS levels, ACSL4 and LPCAT3 protein expressions decreased (<0.01) while GPX4 protein expression increased (<0.01) in synovial tissue in the moxibustion group and moxibustion + ACSL4 inhibitor group. Compared with the moxibustion group, the serum contents of GSH increased (<0.01) while MDA, IL-6, and TNF-α contents decreased (<0.01);the ROS levels, ACSL4 and LPCAT3 protein expressions decreased (<0.01, <0.05) while GPX4 protein expression increased (<0.05) in synovial tissue in the moxibustion + ACSL4 inhibitor group. HE staining showed that the model group had significantly increased synovial hyperplasia and inflammatory cell infiltration;the moxibustion group and moxibustion + ACSL4 inhibitor group showed varying degrees of alleviation in inflammatory cell infiltration and hyperplasia in synovial tissue;compared with the moxibustion group, the moxibustion + ACSL4 inhibitor group showed more significant improvements in inflammatory infiltration and hyperplasia of synovial cells, reduced layers of synovium.

Conclusions: Moxibustion at BL23 and ST36 can alleviate synovial inflammatory injury, and its mechanism may be related to reducing lipid peroxidation and ROS levels, and inhibiting the occurrence of ferroptosis.

Download full-text PDF

Source
http://dx.doi.org/10.13702/j.1000-0607.20240075DOI Listing

Publication Analysis

Top Keywords

acsl4 inhibitor
12
moxibustion
8
mechanism moxibustion
8
ferroptosis-lipid metabolism
8
synovitis inflammatory
8
inflammatory injury
8
injury rheumatoid
8
rheumatoid arthritis
8
group received
8
consecutive days
8

Similar Publications

Obacunone regulates ferroptosis in ovarian cancer through the Akt/p53 pathway.

Naunyn Schmiedebergs Arch Pharmacol

December 2024

Department of Obstetrics and Gynecology, Yantai Hospital of Traditional Chinese Medicine, No.39 Xingfu Road, Zhifu District, Yantai City, 264000, Shandong Province, China.

Ovarian cancer is characterized by a high rate of recurrence and a poor prognosis. Ferroptosis, a programmed cell death that is dependent on iron and lipid peroxidation, has emerged as a novel therapeutic target in recent years. This study investigated the effects of Obacunone, a naturally occurring compound present in citrus fruits, on the induction of ferroptosis in ovarian cancer via the Akt/p53 signaling pathway.

View Article and Find Full Text PDF

Recent studies demonstrate that lipid peroxidation-induced ferroptosis participates in 2,2',4,4'-tetrabromodiphenyl ether (BDE-47)-evoked neurotoxicity and cognitive dysfunction. Melatonin has been indicated to confer neuroprotection against brain diseases via its potent anti-ferroptotic effects. Therefore, this study aims to explore whether melatonin can mitigate BDE-47-elicited cognitive impairment via suppressing ferroptosis, and further delineate the underlying mechanisms.

View Article and Find Full Text PDF

Triple-negative breast cancer (TNBC) has profound unmet medical need globally for its devastating clinical outcome associated with rapid metastasis and lack of targeted therapies. Recently, lipid metabolic reprogramming especially fatty acid oxidation (FAO) has emerged as a major driver of breast cancer metastasis. Analyzing the expression of major FAO regulatory genes in breast cancer, we found selective overexpression of acyl-CoA synthetase 4 (ACSL4) in TNBC, which is primarily attributed to the absence of progesterone receptor.

View Article and Find Full Text PDF

Aortic dissection (AD) poses a significant threat to cardiovascular health globally, yet its underlying mechanisms remain elusive. Smooth muscle cells death and phenotypic switching are critically important pathological processes in AD. Currently, no pharmacological therapies have proven effective in managing AD.

View Article and Find Full Text PDF

Tyrosine phosphatase SHP2 promoted the progression of CRC via modulating the PI3K/BRD4/TFEB signaling induced ferroptosis.

Discov Oncol

December 2024

Department of General Surgery, Bethune International Peace Hospital of The People's Liberation Army, No. 398, Zhongshan XI Road, Qiaoxi District, Shijiazhuang, 050000, Hebei, People's Republic of China.

Objective: To elucidate the mechanism by which tyrosine phosphatase SHP2 protects CRC through modulation of TFEB-mediated ferritinophagy, thereby suppressing ROS and ferroptosis.

Methods: SW480 and SW620 cells, in the logarithmic growth phase, were treated with or without the SHP2 inhibitor PHPS1, the activator Trichomide A, EGF, or MMP inhibitors, and randomly assigned to four groups. Additionally, SW480 cells in the logarithmic phase underwent treatments with EGF, the ferroptosis inducer erastin, Trichomide A, or the curcumin analog C1, forming seven groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!